Muthu Meyyappan has over 20 years’ international experience building and leading diverse, global, cross-cultural teams spanning sales, marketing and customer support for companies within clinical informatics, software/database and genomic products and services markets. Prior to joining Congenica, Muthu served as Chief Commercial Officer for Variantyx and was responsible for the overall commercial strategy for their whole genome testing services for rare disease diagnosis marketed to clinicians and hospitals. Previously, he was the Vice President of Advanced Genomics Commercial Operations for QIAGEN where he was responsible for worldwide revenue for the bioinformatics franchise. He was also Chief Business Officer for BIOBASE GmbH and held senior roles at Incyte Genomics. Muthu has many years of leadership experience in customer facing environments within the pharmaceutical, biotech, academic research and clinical sectors across NA, EMEA and APAC. Muthu holds a Bachelor’s degree in Biotechnology from the Rochester Institute of Technology, New York and a PhD in Cancer Biology from The University of Calgary, Canada.